Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Chapman Tripp Acts for HgCapital in Orion Deal

11 July 2018

Chapman Tripp is advising HgCapital on its acquisition in a majority stake of Orion Healthcare’s core business Rhapsody for $205 million.

Partners John Strowger and Tim Sherman, and solicitor Kit Adamson, are advising the UK private equity firm HgCapital, which has funds of £10 billion under management and an investment focus in technology, in the transaction that will see Hg acquire majority ownership of Rhapsody and also invest in Orion Health's Population Health business.

The transaction is still subject to conditions including Overseas Investment Office approval. Once complete, Orion will use approximately $28 million of the transaction funds to undertake a share buyback offer to retain an ongoing 24.9% shareholding in the Rhapsody business.

The deal marks the middle of a big year for mergers and acquisitions (M&A) for Chapman Tripp. The firm is the leading New Zealand firm by deal count and deal value in “Mergermarket’s H1 2018 M&A league tables” in Australasia. No other law firm in New Zealand has made these tables.

Chapman Tripp is also the leading New Zealand firm by deal involvement announced and completed, according to “Thomson & Reuters First Half 2018 M&A Review” in Australasia (again, no other New Zealand firm has made the tables, and Chapman Tripp is fourth in Australasia for announced deals) as well as the leading New Zealand firm by deal count and deal volume in “Bloomberg’s 1H 2018 M&A Legal Rankings” in Australasia.

Partner Tim Tubman, who heads Chapman Tripp’s national corporate group, said predictions of a strong pipeline of M&A activity fuelled by cashed-up strategic investors and private equity buyers were proving correct.

“The solid M&A deal volumes of last year have continued, but unlike last year, we are seeing a resurgence in mega-deals, such as Cigna Corporation’s purchase of ANZ Bank New Zealand’s business OnePath Life NZ for $700m, in which we advised ANZ, and the sale of Shell New Zealand to Vienna-based oil and gas company OMV for $794m.”


© Scoop Media

Business Headlines | Sci-Tech Headlines


Geothermal: World-Leading Silica Extraction Project

Geo40, in cooperation with Contact Energy and the Ngati Tahu Tribal Lands Trust, is this month set to start commercially extracting silica from geothermal fluid as part of a world-leading sustainable energy partnership. More>>

Electrical Vehicles: New Database of Charging Stations

EVRoam, a real-time database of public charging infrastructure, provides one view of a safe, reliable and interoperable public charging network for electric vehicles in New Zealand. More>>


FMA Mulls Legal Action: Customers Not Focus At Insurers

Most firms had processes in place to identify when a customer was being advised to replace life or health insurance... Generally, these processes seemed oriented towards reducing firms’ legal risk, rather than to identifying and mitigating risks for customers. More>>


Brands Sale To RJ's: Nestle Job Losses “A Bolt From The Blue”

E tū has about 200 members at the plant, where up to 55 workers could lose their jobs... Well-known Kiwi brands affected by the sale include Mackintosh’s, Heards, Black Knight liquorice, Life Savers and Oddfellows. More>>


'Sanctuaries': New Seabed Mining Project Threatens Endangered Species

Greenpeace is shocked to discover that a new seabed mining exploration permit has been awarded inside a Marine Mammal Sanctuary, and is calling on the Government to reject all attempts to mine the seabed. More>>